Next Article in Journal
A Mathematical Model of Metformin Action on COVID-19 Risk Infection in Cardiovascular Diabetic Patients Studied by FTIR Spectroscopy
Previous Article in Journal
Functional Genomics: From Soybean to Legume
Previous Article in Special Issue
The Association of Resistin with Metabolic Health and Obesity in a Mexican-American Population
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Intestinal Immune System Expression of Coho Salmon Challenged with Oxytetracycline: In Vivo and In Vitro Approach

by
Daniela Nualart
1,2,3,*,
José Luis P. Muñoz
4,* and
Luis Vargas-Chacoff
1,2,3,5
1
Instituto de Ciencias Marinas y Limnológicas, Laboratorio de Fisiología de Peces, Universidad Austral de Chile, Valdivia 5090000, Chile
2
Millennium Institute Biodiversity of Antarctic and Subantarctic Ecosystems, BASE, University Austral of Chile, Valdivia 5090000, Chile
3
Centro FONDAP de Investigación en Dinámica de Ecosistemas Marinos de Altas Latitudes (IDEAL), Universidad Austral de Chile, Valdivia 5090000, Chile
4
Centro de Investigación y Desarrollo I~Mar, Universidad de Los Lagos, Puerto Montt 5480000, Chile
5
Integrative Biology Group, Universidad Austral de Chile, Valdivia 5090000, Chile
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(13), 6330; https://doi.org/10.3390/ijms26136330
Submission received: 11 April 2025 / Revised: 11 June 2025 / Accepted: 12 June 2025 / Published: 30 June 2025
(This article belongs to the Special Issue Cytokines in Inflammatory Signaling: 2nd Edition)

Abstract

Oxytetracycline (OTC) has served as an antibiotic to treat various bacterial infections in fish raised in aquaculture. Nonetheless, administering OTC in overly high doses can lead to adverse side effects in fish and also negatively impact on their surroundings. The objective of this work was to evaluate the expression levels of immune markers such as TLR-1, TLR-2, IκB-α, MyD88, NF-κB, IFN-γ, and IL-6 in intestinal cell primary culture (foregut, midgut, and hindgut) using qRT-PCR, and in addition, to assess the in vivo response to different doses of OTC in coho salmon at different times. The expression levels of all genes increased significantly after 1 h on day 1 with high doses of OTC compared with control conditions in all tissues under both approaches (in vivo and in vitro). However, the transcriptional responses decreased to 3, 6, and 12 h in vitro and day 3 in vivo. In conclusion, the transcriptional responses were differentially modulated by OTC in the three intestinal portions under both experimental conditions. These results demonstrate for the first time in primary cell culture fish that the expression of immune biomarkers in all tissues induces a differential response of these genes, depending on the concentration of OTC and the kinetics of time. This study offers valuable insights that can be applied to enhance aquaculture, determine optimal drug doses, and improve fish health.

1. Introduction

The immune system is divided into two primary sections: the innate immune system and the adaptive immune system. The innate immune system serves as the first line of defense against infections and illnesses, but it lacks the ability to remember previous encounters [1,2]. On the other hand, the adaptive immune system is designed to target specific antigens and can provide lasting immunity [3]. This aspect of the immune system is vital for the well-being and survival of fish in aquatic environments. The immune response in fish is a sophisticated process that involves the coordination of various tissues and cells, such as those found in the head kidney and spleen. The head kidney has a hematopoietic function; it is the principal organ for phagocytosis and antigen processing and is the primary site for antibody production [4,5]. The spleen also functions as a major secondary immune organ and plays a significant role in the clearance of bloodborne antigens and antigen presentation and initiation of adaptive immune response [6]. Both tissues play a crucial role in defending against pathogens and regulating the immune response [7,8,9]. However, several external issues, including environmental factors, biological factors, stress, and internal factors such as genetic makeup, age, sex, and maternal effects, can affect the immunological defense capabilities of fish [7,10,11]. Temperature, salinity, and stress can significantly affect the immune response of fish [12,13,14]. For example, changes in temperature and oxygen levels can alter the expression of immunity-related genes [15,16,17], while salinity can affect the function of immune cells in Scatophagus argus [18]. Furthermore, chronic stress can weaken the fish’s immune system, making them more susceptible to disease [19,20]. Stress is an occurrence that many animals undergo, triggering a variety of reactions that engage the three main regulatory systems: the neural, endocrine, and immune systems. In situations where the stress factor is acute and of short duration, the response pattern tends to be stimulating, and the immune response in fish enters an activating phase that primarily boosts innate responses [20]. In this sense, stress may cause high consumption of energy reserves with reallocation of metabolic energy, which interferes negatively with physiological processes such as immunological capacity, influencing the ability to resist infection processes by modulating several immune system components [11]. If the stressor is chronic, the immune response exhibits suppressive effects, and consequently, the likelihood of infection may be increased [21]. For this reason, the use of antibiotics in the diet of salmon, particularly oxytetracycline [22], for both therapeutic and prophylactic purposes have been shown to pose an increasing challenge in the aquaculture industry [23]. Oxytetracycline (OTC) is one of the most used antibiotics in aquaculture [24]. Owing to its broad antibiotic spectrum and low cost [25], it is widely used to prevent and treat bacterial fish diseases [26]. However, this use can have a negative impact on fish health and the environment. Prolonged use can lead to antibiotic resistance, posing a significant threat to global health [27]. Although interactions between antibiotics and the fish immune system have been reported in the literature in turbot, sea bream, Atlantic cod, rainbow trout, gilthead seabream, and coho salmon [28,29,30,31,32], the potential negative effects of these therapeutics on fish immune responses and health have been largely overlooked. In particular, eliminating pathogenic bacteria using antibiotic treatments requires a well-functioning fish immune system [33]. The presence of immune cells and their response have been well studied in the gut of common carp [34], European sea bass [35,36], and Atlantic salmon [37]. In addition, antibiotics may negatively affect gut bacterial diversity in Salmo salar [38,39] and the liver and antioxidant systems [40], which can indirectly impact the fish’s immune function. The intestine is a crucial component of the fish digestive system, actively promoting the fish’s healthy growth and development and serving as a vital immune barrier [34,35,36,37,38,39,40,41]. Moreover, previous functional studies based on transcriptomic analyses have attributed distinct functions to the segments of the European seabass intestine [41,42]. The different sections of the fish’s gut (anterior, middle, and posterior) play a critical role in nutrient absorption and regulating the immune response. Each intestinal region fulfills specific physiological functions, including digestion, absorption, regulation, and balance, and contributes to the immune system. In addition, gene expressions have been shown to vary between these portions depending on the type of stressor or pathogen present [43].
Exposure to environmental factors and the use of antibiotics can impact the function and structure of these intestinal portions, potentially leading to negative consequences for the fish’s health. This work aimed to evaluate the expression levels of immune markers such as TLR-1, TLR-2, IκB-α, MyD88, NF-κB, IFN-γ, and IL-6 in the foregut, midgut, and hindgut of coho salmon exposed to different doses of OTC under two approaches (in vitro and in vivo).

2. Results

2.1. In Vitro Experiments

2.1.1. Foregut

When evaluating the gene expression of different immune markers, we observed a similar pattern in each gene assayed, with a significant increase at the first hour with respect to the control group for all doses of OTC (Figure 1).
The expression of toll-like receptor 1 “TLR-1” also increased at 3 h at the highest dose (Figure 1A). As for TLR-2, its expression increased only at 12 h at the highest dose (Figure 1B). Expressions of myeloid differentiation primary response 88 “MyD 88” also increased at 12 h, at the lowest dose 0.25 μg/mL and at 1.5 μg/mL (Figure 1C). Likewise, an increase in the transcripts of inhibitor α or “IκB-α” was observed at 3, 6 and 12 h with doses of 0.5, 0.25, and 3 μg/mL, respectively (Figure 1D). On the other hand, nuclear factor κB “NF-κB” maintained its high expression at 3 h with the lowest doses of 0.25 μg/mL and 0.5 μg/mL (Figure 1E). Interferon-gamma mRNA “INF-γ” increased in expression at 3, 6, and 12 h of exposure to the high dose (Figure 1F). Finally, the expression of interleukin 6 (IL-6) decreased significantly at 3, 6, 12, and 24 h of exposure to all doses (Figure 1G).

2.1.2. Midgut

A significant increase in TLR-1 transcripts at 1 and 24 h was observed compared to the control group with the high dose of OTC (3 μg/mL), as well as with doses of 0.25 and 0.5 μg/mL (Figure 2A). As for TLR-2 expression, it only increased with the 0.25 μg/mL dose at 1, 3, and 24 h. However, at 6 h, its expression only increased when exposed to the highest dose of 3 μg/mL of OTC (Figure 2B). MyD 88 and IKB-α expressions increased with exposure to the highest dose of 3 μg/mL at 1 h and with the lowest dose of 0.25 μg/mL at 6 h. (Figure 2C,D). Similarly, at 1 and 6 h of exposure to OTC, the mRNA of NF-κB increased; however, at 12 h, its expression decreased significantly. The other experimental doses (low and intermediate) caused increases only at 24 h (Figure 2E). On the other hand, INF-γ mRNA increased at 1 and 6 h with the highest OTC dose of 3 μg/mL and at 6 and 24 h of exposure to the low dose of 0.25 μg/mL (Figure 2F). IL-6 expression also increased significantly at 3, 12, and 24 h of exposure to the intermediate dose of 1.5 μg/mL. The high dose increased the transcripts of this gene at 1 and 24 h of exposure (Figure 2G).

2.1.3. Hindgut

A similar pattern was noted in all markers, where overexpression was seen at 24 h of exposure to OTC at the three highest doses in the experiment (0.5, 1.5, and 3 μg/mL) compared to the control group (Figure 3), with just one exception: IKB-α. Downregulation was observed in TLR-1 expression at 1, 3, 6, and 12 h of exposure to all concentrations of OTC used in the in vitro experiment (Figure 3A). TLR-2 and IL-6 expression increased only at 3 h of exposure to doses of 0.25, 0.5, and 1.5 μg/mL of OTC (Figure 3B,G). On the other hand, MyD88 and NF-κB expression decreased at 1, 3, 6, 12, and 24 h with a dose of 0.25 μg/mL of OTC (Figure 3C,E). The highest level of IKB-α expression occurred after one hour of exposure (Figure 3D). IFN-γ also showed overexpression at 1 h with the highest doses (Figure 3E). Finally, IL-6 expression showed downregulation throughout the kinetics of in vitro exposure to OTC, except at 24 h, where a significant increase was observed with doses of 0.5, 1.5, and 3 μg/mL of OTC.

2.2. In Vivo Experiment

2.2.1. Foregut

The toll-like receptor TLR-1 presented overexpression on day 1 in both cases in the control group after both doses, with the gene expression levels decreasing (Figure 4A). Regarding expression of TLR-2 and NF-κB, only a significant 2.5-fold increase was observed compared to the control group when exposed to the high dose. However, on day 5, a significant decrease was observed with both OTC doses (Figure 4B,E). When transcript levels of myeloid differentiation primary response 88 (MyD88) and interferon-gamma (IFN-γ) were analyzed, they increased significantly, about 5-fold on day 5 with low and high doses of OTC, compared with the control group (Figure 4C,F). Concerning the levels of NF-κB inhibitor α (IκB-α) and interleukin 6 (IL-6), there was an elevation observed at 3 and 5 days following stimulation with both low and high doses, showing less than a fivefold increase compared to the control condition (Figure 4D,G).

2.2.2. Midgut

TLR-1, TLR-2, MyD88, IKB-α, NFK-β, and IL-6 gene expression presented a similar pattern to the control group. At the same time, IFN-γ on day 5 showed a significant “3- to 5-fold” increase in fish exposed to low and high doses compared to the control group (Figure 5A–F).

2.2.3. Hindgut

Gene expression of TLR-1 and IκB-α in this intestinal portion decreased significantly with both doses on days 1 and 3. On the contrary, an increase was observed on day 5 in fish (approx. 3-fold) exposed to the high dose compared to the control group (Figure 6A,D). Regarding TLR-2 and NF-κB expression, downregulation was observed compared to the control group when the fish were exposed to the high dose, but only NF-κB presented statistical differences (Figure 6B,E). Additionally, MyD88 expression increased only on day 5 following exposure to the high dose of OTC. However, a decrease was observed on day 1 and day 3 when the fish were exposed to the high and low doses, respectively (Figure 6C). The immune marker with the highest expression was IFN-γ, where overexpression was significant on day 3 and day 5 post-exposure, increasing more than 100- and 400-fold, compared to the control group (Figure 6F). Finally, IL-6 expression decreased significantly on day 1 of exposure to both doses. Contrary to day 3, it was increased at low doses (Figure 6G).

3. Discussion

Research on the immune response in fish, particularly in salmonid species, has proven essential for understanding how antibiotic treatments, such as OTC, affect health and immunity. In this study, we present new findings on the immune response of coho salmon, explicitly examining the expression of immune genes of the intestine in three intestinal portions following exposure to varying doses of OTC using two approaches: in vivo and in vitro.
The intestine has the highest number of immune cells in any body tissue. It is constantly exposed to a variety of antigens and potential immune triggers. However, many studies overlook that the intestinal tract comprises different regions with distinct anatomical and physiological characteristics and gene expression patterns [44]. In particular, we highlight that the transcriptional responses of genes such as IL-6, IFN-γ, and NF-κB can present peaks of activation followed by upregulation, which is consistent with the literature on immunotoxicology in fish [26,28]. The observed variability may also be influenced by intestinal segmentation (foregut, midgut, hindgut), since each region has a different immune cell density, associated microbiota, and absorption capacity, factors that affect gene expression kinetics [39,41].
The in vitro experiment revealed a pattern of increase at early activation; at 1 h of exposure to OTC, the highest doses, ranging from 0.5 to 3 μg/mL, showed the most significant effect in the anterior intestinal part (foregut), also exhibiting a dose-dependent pattern in all immune markers. This finding is consistent with the study by Tafalla et al. (1999) [28], in which OTC was administered orally over 12 days and combined with OTC baths on days 1, 3, and 5. Observations showed that after exposure, the head kidney macrophages’ respiratory burst and phagocytosis were restricted by the in vitro treatment, and this was dose-dependent for several immune functions in turbot (Scophthalmus maximus L.). Several studies have shown the activation of innate immunity in fish exposed to OTC. For example, the activity of phagocytes, which are essential components of the immune system, was increased by 10-day OTC exposure in gilthead seabream (Sparus aurata) [29] and 3-day OTC exposure in common carp (Cyprinus carpio) [45]. Nevertheless, a less pronounced pattern was observed in the middle portion of the intestine compared to the previous one; however, we recorded that the highest dose of 3 μg/mL increased the transcription of all genes at 1 h post OTC exposure and this was sustained at 3, 6, 12, and 24 h. This finding is consistent with the results of Guardiola et al. (2012) [33], who also noted that the OTC concentration in the diet of gilthead seabream (S. aurata) or treatment doses can lead to the upregulation of immune-related genes. Likewise, late gene activation was observed in the in vitro experiment 24 h post exposure to OTC. In this work, 0.5 and 3 μg/mL doses evoked the most significant gene response. IκB-α and NF-κb increased their transcription levels, similar to what was noted in the previous section, with early activation at 1 h. This suggests that innate immunity in fish is a target of OTC, regardless of its mode of action. Although oxytetracycline is used to treat bacterial infections, it presents challenges in aquaculture due to its bioavailability and the side effects that it can generate at the physiological level [6,45]. It can also activate immune signaling pathways and alter internal cellular and molecular functions or mechanisms of intestinal immunity [45]. In the in vivo experiment, we observed a dose-dependent increase on days 3 and 5 post exposure to OTC in the anterior intestinal portion. A similar pattern to that observed in the in vitro experiment was discovered using this approach; both doses (high and low) activated the transcription of immune response genes, promoting the transcription of proinflammatory cytokines such as IL-6 and INF-γ and activating the NF-κb pathway. This is similar to what was observed in the midgut, where these cytokines were also activated on day 5 with both doses of OTC. This is important because mucus production is controlled by immune mediators, including leukotrienes, interferon-γ (IFN-γ), IL-9, and IL-13 [46,47], and the immune response varies along the intestinal tract. A response or pattern similar to that seen in vitro was observed in the hindgut. The later exposure times (6, 12, and 24 h) showed increased TLR-1 and IFN-γ gene levels, primarily with the lower dose. Overall, the gene expression results in the different tissues show interesting patterns. In particular, when the TLR/MyD88/NF-κB pathway is activated, low doses promoting the activation of biochemical innate immunity against bacterial and xenobiotic antigens such as antibiotics [32,45].
TLR-1 expression (at 1 h and on day 1) increased significantly in the foregut after exposure to OTC both in vitro and in vivo, indicating that this portion of the intestine may be susceptible to antibiotic exposure. This is consistent with the results obtained by Vargas-Chacoff et al. (2024) [32], where this increase in the TLR-1 receptor responds to early exposure to OTC and florfenicol (FLO) and promotes the transcription of MyD88 to activate NF-κb, which will then translocate to the nucleus to activate the transcription of proinflammatory cytokines IL-6 and INF-γ in the SHK-1 cell line. Shown to exhibit regional differences in pattern recognition receptors, in addition to their barrier and absorptive functions, intestinal cells express pattern recognition receptors (PRRs), which can be activated to produce mediators that recruit, activate, and condition cells of the immune system [48,49,50], as has been seen in this work. The different regions of the intestine have crucial antibacterial roles, producing antimicrobial peptides such as lysozyme and defensins and regenerating islet-derived protein IIIγ in response to interleukins or following stimulation of Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain 2 (NOD2) [51,52]. This is why marked differences are seen according to response times at the genetic level by intestinal portions.
The difference in immune gene activation times observed between in vitro (1 h) and in vivo (3–5 days) assays is mainly due to physiological and contextual differences between the two models. In the in vitro experiment, intestinal explants were directly exposed to defined concentrations of oxytetracycline (OTC) without systemic barriers or absorption, distribution, and metabolism processes. This direct exposure allows for direct interaction of OTC with tissue epithelial and immune cells, which could explain the early activation of genes such as TLR-1, NF-κB, IL-6, and IFN-γ, observed as early as hour 1. In contrast, in the in vivo model, the mechanisms are more complex: when OTC is administered, it requires intestinal absorption, a systemic step, and eventually accumulation and absorption in tissues. In addition, the immune response in the whole organism involves the activation of multiple intercellular pathways, immune cell recruitment, and feedback to regulate these processes. This process requires more time, which justifies the significant activation of immune genes observed only on days 3 and 5 post exposure. This phenomenon has previously been reported in comparative immunotoxicological studies between in vitro and in vivo models in teleost fish [28,33]. It has been attributed to differences in antibiotic bioavailability, distribution kinetics, and tissue regulation.
Several studies have reported immune responses to OTC exposure in marine fish. For instance, in gilthead seabream (S. aurata), short-term (7 and 14 days) exposure to OTC (4 and 8 mg OTC/g feed) increased the phagocytic capacity and respiratory burst in the head kidney [33]. Our findings on antibiotics, specifically OTC, in experimental in vitro and in vivo studies, which depend on concentration and time, specifically relate to the TLR-1, MyD88, IFN-γ, and NF-κb pathways. The results are consistent with Guardiola et al. (2012) and Vargas-Chacoff et al. (2024) [32,33]. Furthermore, in vitro studies demonstrated that the expression of IFN-γ and IL-6 fluctuated significantly in response to different doses of OTC. In contrast, in vivo studies revealed that IFN-γ expression was notably higher in the hindgut, increasing significantly compared to the control. These findings suggest that cytokine regulation may vary between in vitro and in vivo conditions, underscoring the complexity of the immune response in a biologically relevant environment [31,53,54]. This indicates that the immune response is influenced by exposure duration and the dosage given. In vivo models offer a complex immune response, but in vitro assays with primary cell cultures allow us to isolate and observe direct cellular effects of antibiotics under controlled conditions. These models help detect early molecular changes and toxic thresholds. We observed responses within one hour, aligning with known pharmacokinetics. In vitro and in vivo approaches provide a fuller picture of the impact of antibiotics on fish health.

4. Materials and Methods

The present study used the same specimens and experimental procedures used in Muñoz et al. (2025) [55].

4.1. Animals

For in vitro experiments and injection experiments, healthy specimens of coho salmon (O. kisutch), weighing approximately 500.32 ± 12.4 g, were obtained from Unidad de Producción Acuícola (Universidad de Los Lagos) fish farm (Rupanco Lake, Chile).
For the in vitro experiments, N = 25 fish were transported to the laboratories of the Faculty of Science (Universidad Austral de Chile, Valdivia, Chile) to have portions of their intestines (foregut, midgut, and hindgut) removed and primary cells cultured.
To develop in vivo experiments, immature coho salmon (n = 108, 650 ± 30 g body weight [mean and SD]) were acclimated to seawater for 30 days in 9 tanks of 1000 L each, under natural conditions consisting of a 12:12 light/dark photoperiod, 12 ± 1 °C water temperature, 30 PSU, and continuously renewed and aerated water. During the acclimation period, fish were fed daily at 10:00 a.m. with commercial dry pellets for salmonids (Biomar NEW PW100_AK_CER, caliber 4.0 mm; proximate food analysis: 45–50% crude protein, 21–23% lipids, 9.5% carbohydrates, 12% ashes, 10% water, and 2.5% fiber) at 1% of their body mass.
All fish from in vitro and in vivo experiments were anesthetized with a lethal dose of 2-phenoxyethanol (1 mL/L, Sigma-Aldrich-Fluka (St. Louis, MO, USA), 77,699). The tissues were extracted from each specimen, stored, cultured, or frozen in liquid nitrogen for further analysis [11].
All experimental procedures adhered to the regulations for using laboratory animals, as outlined by the Chilean National Commission for Scientific and Technological Research (ANID) and the Universidad de Los Lagos.

4.2. Intestinal Primary Cell Culture Preparation

Intestinal primary cell culture preparation. For the primary culture, we obtained small pieces of tissue (approximately 10–15 mg) from the explants of the three portions (foregut, midgut, and hindgut) of Oncorhynchus kisutch, which were removed under aseptic conditions [56]. The intestinal portions were used for primary cell culture, which was then seeded and maintained in a six-well plate at 18 °C under an air atmosphere for at least 24 h [56,57]. The medium used for cultivating cells and tissues was Leibovitz’s L-15, with each well containing 1 mL of this medium. This medium was enhanced by adding 10% fetal bovine serum (FBS) sourced from Invitrogen (Gibco, Thermo Fisher, Waltham, MA, USA).

4.3. In Vitro Experimental Treatment

Twenty-four hours after seeding each of the three portions (foregut, midgut, and hindgut) of O. kisutch, we changed the medium to four different doses of oxytetracycline for testing (Merck; CAS No: 79–57 2) (0.25, 0.5, 1.5, and 3 μg/mL) and ensured a control group. The chosen doses are similar to those described by [28] and previously published [32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55]. For kinetic experiments at 1, 3, 6, 12, and 24 h at 18 °C, we added 1 μL/well of the antibiotic solution. Control plates contained the same medium volume without the antibiotic to avoid interference. All the experiments were run in triplicate and independently repeated twice.

4.4. In Vivo Experiment

All in vivo experiments were performed in triplicate (3 tanks per condition); the time course experiment was carried out to evaluate the effect of oxytetracycline by intraperitoneal injection using doses of 75 mg/Kg and 35 mg/Kg (concentrations used for farming), with a control group using vehicle (physiological serum) following a methodology similar to that in [28] and previously published [55]. With N = 108 fish for 5 days, samples were taken on days 1, 3, and 5 post injection. At each sampling time, 12 fish were collected (4 fish per tank, in triplicate) for each experimental condition.

4.5. Total RNA Extraction

Following the kinetic experiments, the cell culture medium was discarded, and 500 μL of TRIzol reagent (Sigma, St. Louis, MO, USA) was added to gather the cells. These cells were then frozen in liquid nitrogen for RNA extraction. Using TRIzol reagent, total RNA was extracted following the manufacturer’s instructions and stored at −80 °C. The concentration of the RNA was determined at a wavelength of 260 nm using a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). To synthesize cDNA, 2 μg of the total RNA was used as the template for the reverse transcription process. According to standard protocols, this was performed using MMLV-RT reverse transcriptase from Promega and an oligo(dT) primer from Invitrogen.

4.6. RT-qPCR Analysis

The reactions were carried out using an AriaMx Real-Time PCR System (Agilent, Santa Clara, CA, USA). The cDNA (100 ng) served as the template for RT-qPCR, using Brilliant SYBR Green qPCR reagents (Stratagene, San Diego, CA, USA). Each reaction, performed in duplicate, had a total volume of 14 μL, with 6 μL of SYBR Green, 2 μL of cDNA, 1.08 μL of primer mix, and 4.92 μL of PCR water. The qPCR program used included an initial denaturation step at 95 °C for 10 min, followed by 40 cycles of denaturation at 90 °C for 10 s, annealing at 60 °C for 15 s, and extension at 72 °C for 15 s. To guarantee the specificity of the amplification process, a melting curve analysis was conducted following each PCR cycle to verify the presence of a singular PCR product. The levels of mRNA expression were determined using the comparative Ct approach (2−ΔΔCT), as outlined by [58,59]. The findings are expressed as the fold change in gene expression, normalized to the endogenous reference gene 18S, and compared to the control group, which consists of unstimulated cells. Table 1 lists the primers utilized for TLR-1, TLR-2, IκB-α, MyD88, NF-κB, IFN-γ, and IL-6. PCR efficiencies were assessed through linear regression analysis of the data, employing LinRegPCR software (version 11.0) [60], which plots the logarithm of serial dilutions against the threshold cycle number (ΔCT).

4.7. Statistical Treatment of Results

All data are presented as the mean ± standard error of the mean (SEM). Potential tank effects were tested for each physiological parameter by nesting replicate tanks within each treatment. No significant tank effects (p > 0.01) were witnessed in the analysis. A two-way analysis of variance (ANOVA) was used with time and treatments (doses) as factors, and the assumptions of normality, independence, and homogeneity of the residuals for the variances between groups were tested using a Shapiro–Wilk test and a Levene test. After that, a two-way ANOVA followed by Tukey’s post hoc test was used to determine whether each factor was significant and to assess the effect of treatment (control, different doses, and days) on gene expression (Table 2). All statistical analyses and graphs were performed with the software SigmaPlot 14.5.

5. Conclusions

The role of the intestinal immune system is to maintain physiological function in the face of constant environmental challenges. There are, however, marked differences in gene expression along the length of the intestine which present distinct challenges to the immune system. As a result, although the various segments of the gastrointestinal tract can deploy a similar battery of immune functions, the exact balance between individual cell types and mechanisms varies considerably along the length of the intestine. The research presented here provides a comprehensive understanding of how OTC exposure impacts the immune response in various sections of the gut of Chilean salmon. The results highlight the complexity of the immune response, which varies not only between in vitro and in vivo conditions but also between different intestinal segments (see Figure 7). These findings have significant implications for aquaculture health and the management of antibiotic resistance, suggesting that antibiotic stewardship should be carefully considered to avoid compromising the immune response in key species for the fishing industry. Future research should comprehensively investigate the interactions between diet, antibiotics, and immune health.

Author Contributions

Conceptualization, D.N., J.L.P.M. and L.V.-C.; methodology, D.N., J.L.P.M. and L.V.-C.; validation, D.N., J.L.P.M. and L.V.-C.; formal analysis, D.N., J.L.P.M. and L.V.-C.; investigation, D.N., J.L.P.M. and L.V.-C.; resources, J.L.P.M. and L.V.-C.; data curation, D.N., J.L.P.M. and L.V.-C.; writing—original draft preparation, D.N., J.L.P.M. and L.V.-C.; writing—review and editing, D.N., J.L.P.M. and L.V.-C.; visualization, D.N., J.L.P.M. and L.V.-C.; supervision, D.N., J.L.P.M. and L.V.-C.; project administration, D.N., J.L.P.M. and L.V.-C.; funding acquisition, J.L.P.M. and L.V.-C. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Fondecyt 1190857, Fondecyt 1250678, Fondap-Ideal, 15150003, and the ANID-Millennium Science Initiative Program-Center code “ICN2021_002”. D. Nualart was awarded the scholarship ANID-Millennium Science Initiative Program-Center code “ICN2021_002” and the APC was funded by the Universidad de Los Lagos.

Institutional Review Board Statement

This study was approved by Audit Bioethical Aspects Research Projects, Los Lagos University (Approval Code: 01/2023; Approval Date: 12 January 2023).

Informed Consent Statement

Not applicable.

Data Availability Statement

Data availability statements are available on request.

Acknowledgments

The authors acknowledge the support provided by the Vicerrectoría de Investigación, Desarrollo y Creación Artística (VIDCA) of the Universidad Austral de Chile and the APC was funded by the Universidad de Los Lagos.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Hamada, A.; Torre, C.; Drancourt, M.; Ghigo, E. Trained immunity carried by non-immune cells. Front. Microbiol. 2019, 9, 3225. [Google Scholar]
  2. Romo, M.R.; Pérez-Martínez, D.; Ferrer, C.C. Innate immunity in vertebrates: An overview. Immunology 2016, 148, 125–139. [Google Scholar] [CrossRef] [PubMed]
  3. Alberts, B.; Johnson, A.; Lewis, J. Chapter 24: The adaptive immune system. In Molecular Biology of the Cell, 4th ed.; Garland Science: New York, NY, USA, 2002. [Google Scholar]
  4. Meseguer, J.; Lopez-Ruiz, A.; Garcia-Ayala, A. Reticulo-endothelial stroma of the head-kidney from the seawater teleost gilthead seabream (Sparus aurata L.): An ultrastructural and cytochemical study. Anat. Rec. 1995, 241, 303–309. [Google Scholar] [CrossRef]
  5. Rauta, P.R.; Nayak, B.; Das, S. Immune system and immune responses in fish and their role in comparative immunity study: A model for higher organisms. Immunol. Lett. 2012, 148, 23–33. [Google Scholar] [CrossRef] [PubMed]
  6. Whyte, S.K. The innate immune response of finfish. A review of current knowledge. Fish Shellfish Immunol. 2007, 23, 1127–1151. [Google Scholar] [CrossRef] [PubMed]
  7. Sahoo, S.; Banu, H.; Prakash, A.; Tripathi, G. Immune system of fish: An evolutionary perspective. In Antimicrobial Immune Response; IntechOpen: London, UK, 2021. [Google Scholar]
  8. Martínez, D.P.; Oliver, C.; Santibañez, N.; Coronado, J.L.; Oyarzún-Salazar, R.; Enriquez, R.; Vargas-Chacoff, L.; Romero, A. PAMPs of Piscirickettsia salmonis Trigger the Transcription of Genes Involved in Nutritional Immunity in a Salmon Macrophage-Like Cell Line. Front. Immunol. 2022, 13, 849752. [Google Scholar] [CrossRef]
  9. Pontigo, J.P.; Saravia, J.; Oyarzún, R.; González, M.P.; Hawes, C.; Morera, F.J.; Pino, J.; Wadsworth, S.; Muñoz, J.L.P.; Vargas-Chacoff, L. Modulation of the Expression of Immune-related gene in Atlantic and Coho Salmon during Infestation with the Sea Lice Caligus rogercresseyi. Fishes 2019, 4, 42. [Google Scholar] [CrossRef]
  10. Cuesta, A.; Vargas-Chacoff, L.; García-López, A.; Arjona, F.; Martínez-Rodríguez, G.; Meseguer, J.; Mancera, J.M.; Esteban, M.A. Effect of sex-steroid hormones, testosterone and estradiol, on humoral immune parameters of gilthead seabream. Fish Shellfish Immunol. 2007, 23, 693–700. [Google Scholar] [CrossRef]
  11. Vargas-Chacoff, L.; Martínez, D.; Oyarzún, R.; Nualart, D.; Olavarría, V.; Yáñez, A.; Bertrán, C.; Ruiz-Jarabo, I.; Mancera, J. Combined effects of high stocking density and Piscirickettsia salmonis treatment on the immune system, metabolism and osmoregulatory responses of the Sub-Antarctic notothenioid fish Eleginops maclovinus. Fish Shellfish Immunol. 2014, 40, 424–434. [Google Scholar] [CrossRef]
  12. Cheng, W.; Chen, J. Effects of pH, temperature and salinity on immune parameters of the freshwater prawn Macrobrachium rosenbergii. Fish Shellfish Immunol. 2000, 10, 387–391. [Google Scholar] [CrossRef]
  13. Martínez, D.; De Lázaro, O.; Cortés, P.; Oyarzún-Salazar, R.; Paschke, K.; Vargas-Chacoff, L. Hypoxia modulates the transcriptional immunological response in Oncorhynchus kisutch. Fish Shellfish Immunol. 2020, 106, 1042–1051. [Google Scholar] [CrossRef]
  14. Saravia, J.; Paschke, K.; Pontigo, J.P.; Nualart, D.; Navarro, J.M.; Vargas-Chacoff, L. Effects of temperature on the innate immune response on Antarctic and sub-Antarctic fish Harpagifer antarcticus and Harpagifer bispinis challenged with two immunostimulants, LPS and Poly I:C: In vivo and in vitro approach. Fish Shellfish Immunol. 2022, 130, 391–408. [Google Scholar] [CrossRef] [PubMed]
  15. Truscott, K.N.; White, K. The influence of metal and temperature stress on the immune system of crabs. Funct. Ecol. 1990, 4, 455–461. [Google Scholar] [CrossRef]
  16. Kazmi, S.; Wang, L.; Cai, Y.; Wang, Z. Temperature effects in single or combined with chemicals to the aquatic organisms: An overview of thermo-chemical stress. Ecol. Indic. 2022, 143, 109354. [Google Scholar] [CrossRef]
  17. Martínez, D.; Vargas-Lagos, C.; Oyarzún, R.; Loncoman, C.A.; Pontigo, J.P.; Yáñez, A.J.; Vargas-Chacoff, L. Temperature modulates the immunological response of the sub-antarctic notothenioid fish Eleginops maclovinus injected with Piscirickettsia salmonis. Fish Shellfish Immunol. 2018, 82, 492–503. [Google Scholar] [CrossRef]
  18. Lu, M.; Su, M.; Liu, N.; Zhang, J. Effects of environmental salinity on the immune response of the coastal fish Scatophagus argus during bacterial infection. Fish Shellfish Immunol. 2022, 124, 401–410. [Google Scholar] [CrossRef]
  19. Tort, L.; Padrós, F.; Rotllant, J.; Crespo, S. Winter syndrome in the gilthead sea bream Sparus aurata: Immunological and histopathological features. Fish Shellfish Immunol. 1998, 8, 37–47. [Google Scholar] [CrossRef]
  20. Tort, L. Stress and immune modulation in fish. Dev. Comp. Immunol. 2011, 35, 1366–1375. [Google Scholar] [CrossRef]
  21. Urbinati, E.C.; Zanuzzo, F.S.; Biller, J.D. Stress and immune system in fish. In Biology and Physiology of Freshwater Neotropical Fish; Elsevier: Amsterdam, The Netherlands, 2020; pp. 93–114. [Google Scholar]
  22. Iida, M.; Nguyen, H.T.; Takahashi, F.; Bak, S.-M.; Kanda, K.; Iwata, H. Effects of exposure to oxytetracycline on the liver proteome of red seabream (Pagrus major) in a real administration scenario. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2022, 256, 109325. [Google Scholar] [CrossRef] [PubMed]
  23. Shulgina, L.V.; Yakush, E.V.; Shulgin, Y.P.; Shenderyuk, V.V.; Chukalova, N.N.; Baholdina, L.P. Antibiotics in aquaculture and their ecological significance. A review. Izvestiya TINRO 2015, 181, 216–230. (In Russian) [Google Scholar] [CrossRef]
  24. Sapkota, A.; Sapkota, A.R.; Kucharski, M.; Burke, J.; McKenzie, S.; Walker, P.; Lawrence, R. Aquaculture practices and potential human health risks: Current knowledge and future priorities. Environ. Int. 2008, 34, 1215–1226. [Google Scholar] [CrossRef]
  25. Chopra, I.; Roberts, M. Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 2001, 65, 232–260. [Google Scholar] [CrossRef]
  26. Yang, C.; Song, G.; Lim, W. A review of the toxicity in fish exposed to antibiotics. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2020, 237, 108840. [Google Scholar] [CrossRef] [PubMed]
  27. Llor, C.; Bjerrum, L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Ther. Adv. Drug Saf. 2014, 5, 229–241. [Google Scholar] [CrossRef] [PubMed]
  28. Tafalla, C.; Novoa, J.M.; Alvarez, A.; Figueras, A. In vivo and in vitro effect of oxytetracycline treatment on the immune response of turbot, Scophthalmus maximus (L.). J. Fish Dis. 1999, 22, 271–276. [Google Scholar] [CrossRef]
  29. Serezli, H.; Cagirgan, I.; Okumus, S.; Akhan, F.; Balta, I. The effect of oxytetracycline on non-specific immune response in sea bream (Sparus aurata L. 1758). Turk. J. Vet. Anim. Sci. 2005, 29, 31–35. [Google Scholar]
  30. Caipang, C.M.; Lazado, C.; Brinchmann, F.; Berg, I.; Kiron, V. In vivo modulation of immune response and antioxidant defense in Atlantic cod, Gadus morhua following oral administration of oxolinic acid and florfenicol. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2009, 150, 459–464. [Google Scholar] [CrossRef] [PubMed]
  31. Lunden, S.; Miettinen, L.G.; Lonnstrom, E.M.; Lilius, C.; Bylund, G. Effect of florfenicol on the immune response of rainbow trout (Oncorhynchus mykiss). Vet. Immunol. Immunopathol. 1999, 67, 317–325. [Google Scholar] [CrossRef]
  32. Vargas-Chacoff, L.; Figueroa, D.; Nualart, D.; Muñoz, J.L. The oxytetracycline and florfenicol effect on the immune system and oxidative stress response of the SHK-1 cell line of Salmo salar. Fishes 2024, 9, 493. [Google Scholar] [CrossRef]
  33. Guardiola, R.; Cerezuela, J.; Meseguer, M.A.; Esteban, M.A. Modulation of the immune parameters and expression of genes of gilthead seabream (Sparus aurata L.) by dietary administration of oxytetracycline. Aquaculture 2012, 334, 51–57. [Google Scholar] [CrossRef]
  34. Rombout, J.H.; Taverne-Thiele, A.J.; Villena, M.I. The gut associated lymphoid tissue (GALT) of carp (Cyprinus carpio L.): An immunocytochemical analysis. Dev. Comp. Immunol. 1993, 17, 55–66. [Google Scholar] [CrossRef]
  35. Abelli, L.; Picchietti, S.; Romano, N.; Mastrolia, L.; Scapigliati, G. Immunohistochemistry of gut-associated lymphoid tissue of the sea bass Dicentrarchus labrax. Fish Shellfish Immunol. 1997, 7, 235–245. [Google Scholar] [CrossRef]
  36. Scapigliati, G.; Romano, N.; Buonocore, F.; Picchietti, S.; Baldassini, M.R.; Prugnoli, D.; Galice, A.; Meloni, S.; Secombes, C.; Mazzini, M. The immune system of sea bass, Dicentrarchus labrax, reared in aquaculture. Dev. Comp. Immunol. 2002, 26, 151–160. [Google Scholar] [CrossRef] [PubMed]
  37. Zanuzzo, F.; Sandrelli, R.; Peroni, F.; Hall, J.R.; Rise, M.L.; Gamperl, A.K. Atlantic salmon (Salmo salar) bacterial and viral innate immune responses are not impaired by florfenicol or tetracycline administration. Fish Shellfish Immunol. 2022, 123, 298–313. [Google Scholar] [CrossRef]
  38. Navarrete, P.; Mardones, P.; Opazo, R.; Espejo, R.; Romero, J. Oxytetracycline treatment reduces bacterial diversity of intestinal microbiota of Atlantic salmon. J. Aquat. Anim. Health 2008, 20, 177–183. [Google Scholar] [CrossRef]
  39. Tapia-Paniagua, S.; Vidal, S.; Lobo, C.; De La Banda, I.G.; Esteban, M.; Balebona, M.; Moriñigo, M. Dietary administration of the probiotic SpPdp11: Effects on the intestinal microbiota and immune-related gene expression of farmed Solea senegalensis treated with oxytetracycline. Fish Shellfish Immunol. 2015, 46, 449–458. [Google Scholar] [CrossRef]
  40. Reda, R.M.; Ibrahim, R.; Ahmed, N.; El-Bouhy, Z. Effect of oxytetracycline and florfenicol as growth promoters on the health status of cultured Oreochromis niloticus. Egypt. J. Aquat. Res. 2013, 39, 241–248. [Google Scholar] [CrossRef]
  41. Fu, S.; Qian, K.; Tu, X.; Lu, J.; Yao, T.; Ye, L.; Ye, J. Comparative analysis of intestinal structure, enzyme activity, intestinal microbiota and gene expression in different segments of pufferfish (Takifugu obscurus). Comp. Biochem. Physiol. Part D Genom. Proteom. 2024, 52, 101341. [Google Scholar] [CrossRef]
  42. Calduch-Giner, J.A.; Sitja-Bobadilla, A.; Perez-Sanchez, J. Gene expression profiling reveals functional specialization along the intestinal tract of a carnivorous teleostean fish (Dicentrarchus labrax). Front. Physiol. 2016, 7, 359. [Google Scholar]
  43. Díaz-Ibarrola, D.; Martínez, D.; Vargas-Lagos, C.; Saravia, J.; Vargas-Chacoff, L. Transcriptional modulation of immune genes in gut of Sub-Antarctic notothenioid fish Eleginops maclovinus challenged with Francisella noatunensis subsp. noatunensis. Fish Shellfish Immunol. 2022, 124, 56–65. [Google Scholar] [CrossRef]
  44. Mowat, A.M.; Agace, W.W. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 2014, 14, 667–685. [Google Scholar] [CrossRef]
  45. Kondera, E.; Bojarski, B.; Ługowska, K.; Kot, B.; Witeska, M. Effects of oxytetracycline and gentamicin therapeutic doses on hematological, biochemical and hematopoietic parameters in Cyprinus carpio juveniles. Animals 2020, 10, 2278. [Google Scholar] [CrossRef]
  46. Bancroft, A.; McKenzie, A.; Grencis, R. A critical role for IL-13 in resistance to intestinal nematode infection. J. Immunol. 1998, 160, 3453–3461. [Google Scholar] [CrossRef] [PubMed]
  47. Steenwinckel, V.; Louahed, J.; Lemaire, M.; Sommereyns, C.; Warnier, G.; McKenzie, A.; Brombacher, F.; Van Snick, J.; Renauld, J. IL-9 promotes IL-13-dependent Paneth cell hyperplasia and upregulation of innate immunity mediators in intestinal mucosa. J. Immunol. 2009, 182, 4737–4743. [Google Scholar] [CrossRef]
  48. Zaph, C.; Troy, A.; Taylor, B.; Berman-Booty, L.; Guild, K.J.; Du, Y.; Yost, E.; Gruber, A.; May, M.; Greten, F. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis. Nature 2007, 446, 552–556. [Google Scholar] [CrossRef]
  49. Rescigno, M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol. 2011, 32, 256–264. [Google Scholar] [CrossRef] [PubMed]
  50. Maldonado-Contreras, A.L.; McCormick, B.A. Intestinal epithelial cells and their role in innate mucosal immunity. Cell Tissue Res. 2011, 343, 5–12. [Google Scholar] [CrossRef]
  51. Ouellette, A.J. Paneth cells and innate mucosal immunity. Curr. Opin. Gastroenterol. 2010, 26, 547–553. [Google Scholar] [CrossRef]
  52. Clevers, H.C.; Bevins, C.L. Paneth cells: Maestros of the small intestinal crypts. Annu. Rev. Physiol. 2013, 75, 289–311. [Google Scholar] [CrossRef] [PubMed]
  53. Lunder, T.; Aas, H.; Kaur, M. Environmental factors influencing immune responses in farmed fish. Aquac. Res. 2020, 51, 1–10. [Google Scholar]
  54. Georgopoulou, U.; Vernier, J. Local immunological response in the posterior intestinal segment of the rainbow trout after oral administration of macromolecules. Dev. Comp. Immunol. 1986, 10, 529–537. [Google Scholar] [CrossRef]
  55. Muñoz, J.L.; Martínez, D.; Nualart, D.P.; Mardones, O.; Delmoral, I.; Morera, F.; Vargas-Chacoff, L. Antibiotic oxytetracycline is affecting the dynamics of serotonergic response in brain of coho salmon. Aquaculture 2025, 603, 742376. [Google Scholar] [CrossRef]
  56. Lee, J.; Cuddihy, M.J.; Kotov, N.A. Three-dimensional cell culture matrices: State of the art. Tissue Eng. Part B Rev. 2008, 14, 61–86. [Google Scholar] [CrossRef] [PubMed]
  57. Nualart, D.P.; Dann, F.; Oyarzún-Salazar, R.; Morera, F.J.; Vargas-Chacoff, L. Immune transcriptional response in head kidney primary cell cultures isolated from the three most important species in Chilean salmonids aquaculture. Biology 2023, 12, 924. [Google Scholar] [CrossRef] [PubMed]
  58. Namdari, R.; Abedini, S.; Law, F.C.P. A comparative tissue distribution study of oxytetracycline in rainbow trout, Oncorhynchus mykiss (Walbaum), and chinook salmon, Oncorhynchus tshawytscha (Walbaum). Aquac. Res. 1999, 30, 279–286. [Google Scholar] [CrossRef]
  59. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
  60. Ramakers, C.; Ruijter, J.M.; Deprez, R.H.L.; Moorman, A. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 2003, 339, 62–66. [Google Scholar] [CrossRef]
  61. Pedro, A.V.F.; Martínez, D.; Pontigo, J.P.; Vargas-Lagos, C.; Hawes, C.; Wadsworth, S.; Morera, F.J.; Vargas-Chacoff, L.; Yáñez, A.J. Transcriptional activation of genes involved in oxidative stress in Salmo salar challenged with Piscirickettsia salmonis. Comp. Biochem. Physiol. Part B Biochem. Mol. Biol. 2019, 229, 18–25. [Google Scholar] [CrossRef]
Figure 1. Gene expression in the primary culture of the foregut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Figure 1. Gene expression in the primary culture of the foregut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Ijms 26 06330 g001
Figure 2. Gene expression in the primary culture of the midgut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Figure 2. Gene expression in the primary culture of the midgut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Ijms 26 06330 g002
Figure 3. Gene expression in the primary culture of the hindgut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a–e) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Figure 3. Gene expression in the primary culture of the hindgut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a–e) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Ijms 26 06330 g003
Figure 4. Gene expression in vivo of the foregut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Figure 4. Gene expression in vivo of the foregut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Ijms 26 06330 g004
Figure 5. Gene expression in vivo of the midgut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Figure 5. Gene expression in vivo of the midgut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Ijms 26 06330 g005
Figure 6. Gene expression in vivo of the hindgut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Figure 6. Gene expression in vivo of the hindgut of O. kisutch treated with oxytetracycline (OTC). (A) TLR-1, (B) TLR-2, (C) MyD88, (D) IκB-α, (E) NF-κb, (F) INF-γ, and (G) IL-6. The relative expression of genes was calculated using the comparative Ct method (2−ΔΔCT), with the 18S ribosomal protein as the internal reference gene. Each value represents the mean ± S.E.M. Different letters (a,b,c) indicate statistical differences at the same time point and between treatments. Symbols (*, #, +) over the bars indicate statistical differences of treatments (control and different doses of antibiotic) at different time points. Two-way ANOVA followed by Tukey’s test (p < 0.05).
Ijms 26 06330 g006
Figure 7. A summary of all of the responses evaluated in this work under both approaches (in vitro and in vivo). The green arrows correspond to an increase and the blue arrows correspond to a decrease in the transcripts of the immunological markers.
Figure 7. A summary of all of the responses evaluated in this work under both approaches (in vitro and in vivo). The green arrows correspond to an increase and the blue arrows correspond to a decrease in the transcripts of the immunological markers.
Ijms 26 06330 g007
Table 1. Primer sequences for expression analysis.
Table 1. Primer sequences for expression analysis.
PrimerNucleotide Sequences (5′→3′)Efficiency (%) ForegutEfficiency (%) MidgutEfficiency (%) HindgutGenBank No/Reference
TLR-1 FwTCCGGAGACGTTTCATCCCA101.6101.7102.91MF945984
TLR-1 RvGAGGTTCAGCGCTAACAGCA
TLR-2 FwGGGTCTAACTGGGAAGCAGC 100.1100.2100.1Martinez et al., 2020 [13]
TLR-2 RvAACGGAATGAGACGGATGGG
MyD 88 FwCTTTCACAACCACCGAAGCC102.71100.3101.6Martinez et al., 2018 [17]
MyD 88 RvTACAAACCGAAACCGCTCCT
INF-γ FwGCCGTGTGTTGGTTTTTGATTT102.72100.1100.1Martinez et al., 2018 [17]
INF-γ RvGTGTCTGTCTGACTGATGGTGA
NFκ-b FwAAAGTGCCAGTACCAAGCCC100.1101.6102.5Martinez et al., 2018 [17]
NFκ-b RvCATGCTGATGAGCTACTGTTGTT
IL-6 FwGAGCTACGTAACTTCCTGGTTGAC 102.1100.3102.1Martinez et al., 2020 [13]
IL-6 RvGCAAGTTTCTACTCCAGGCCTGAT
IkB-α FwTCTGCCACCAGCTGTATGA102.5100.1100.1BT074199.1
IkB-αRvTCTGCCCGAATGTAATGTCA
18S FwGTCCGGGAAACCAAAGTC101.6102.5102.1Pedro et al., 2019 [61]
18S FwTTGAGTCAAATTAAGCCGCA
Table 2. p-values from the two-way ANOVA for separate time and doses and the interaction of parameters (time × doses). Statistical differences between different tissues: NS, not significant; significant, p < 0.01.
Table 2. p-values from the two-way ANOVA for separate time and doses and the interaction of parameters (time × doses). Statistical differences between different tissues: NS, not significant; significant, p < 0.01.
TissueGenesIn VitroIn Vivo
TimeDosesTime × DosesTimeDosesTime × Doses
ForegutTLR-1<0.0001<0.0001<0.0001<0.0001<0.0001<0.0001
MidgutTLR-1<0.0001<0.0001<0.0001<0.0001<0.0001<0.0001
HindgutTLR-1<0.0001<0.0001<0.0001<0.0001NSNS
ForegutTLR-2<0.0001NS<0.0001<0.0001<0.0001<0.0001
MidgutTLR-2<0.0001<0.0001<0.0001NS0.0077<0.0001
HindgutTLR-2<0.0001<0.0001<0.0001<0.0001<0.0001<0.0001
ForegutMyD 88 <0.00010.0001<0.0001<0.0001<0.0001<0.0001
MidgutMyD 88 <0.0001<0.0001<0.0001NS<0.00010.0004
HindgutMyD 88 <0.0001<0.0001<0.00010.0002NS0.0156
ForegutIkB-α <0.0001<0.0001<0.0001<0.0001<0.00010.0006
MidgutIkB-α 0.00370.0111<0.00010.0008<0.00010.0001
HindgutIkB-α <0.0001<0.0001<0.0001<0.00010.0048<0.0001
ForegutINF-γ <0.0001<0.0001<0.0001<0.00010.0105<0.0001
MidgutINF-γ <0.0001<0.0001<0.0001<0.0001<0.0001<0.0001
HindgutINF-γ <0.0001<0.0001<0.0001<0.0001<0.0001<0.0001
ForegutIL-6<0.0001<0.0001<0.0001<0.0001<0.00010.0019
MidgutIL-6<0.0001<0.0001<0.0001<0.00010.0103<0.0001
HindgutIL-6<0.0001<0.0001<0.0001<0.0001NS0.0002
ForegutNFκ-b <0.0001<0.0001<0.0001<0.0001NS<0.0001
MidgutNFκ-b <0.0001<0.0001<0.00010.0063NSNS
HindgutNFκ-b <0.0001<0.0001<0.0001NS<0.0001NS
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nualart, D.; Muñoz, J.L.P.; Vargas-Chacoff, L. Intestinal Immune System Expression of Coho Salmon Challenged with Oxytetracycline: In Vivo and In Vitro Approach. Int. J. Mol. Sci. 2025, 26, 6330. https://doi.org/10.3390/ijms26136330

AMA Style

Nualart D, Muñoz JLP, Vargas-Chacoff L. Intestinal Immune System Expression of Coho Salmon Challenged with Oxytetracycline: In Vivo and In Vitro Approach. International Journal of Molecular Sciences. 2025; 26(13):6330. https://doi.org/10.3390/ijms26136330

Chicago/Turabian Style

Nualart, Daniela, José Luis P. Muñoz, and Luis Vargas-Chacoff. 2025. "Intestinal Immune System Expression of Coho Salmon Challenged with Oxytetracycline: In Vivo and In Vitro Approach" International Journal of Molecular Sciences 26, no. 13: 6330. https://doi.org/10.3390/ijms26136330

APA Style

Nualart, D., Muñoz, J. L. P., & Vargas-Chacoff, L. (2025). Intestinal Immune System Expression of Coho Salmon Challenged with Oxytetracycline: In Vivo and In Vitro Approach. International Journal of Molecular Sciences, 26(13), 6330. https://doi.org/10.3390/ijms26136330

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop